Anonymous
Guest
Anonymous
Guest
“We have tried repeatedly to engage in a constructive process with AstraZeneca to explore a combination of our two companies,” Pfizer’s chief executive, Ian C. Read, said in a statement. “Following a conversation with AstraZeneca earlier today, we do not believe that the AstraZeneca board is currently prepared to recommend a deal at a reasonable price.”